Assertio Therapeutics Inc (ASRT):企業の財務・戦略的SWOT分析

◆英語タイトル:Assertio Therapeutics Inc (ASRT) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1328
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Assertio Therapeutics Inc (ASRT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Assertio Therapeutics Inc (Assertio), formerly Depomed Inc, is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain and other diseases of central nervous system. Its marketed product portfolio includes Gralise (gabapentin tablets) for the management of postherpetic neuralgia (PHN), Cambia for acute migraine attacks in adults, and Zipsor for mild to moderate acute pain in adults. The company sells its products to wholesale distributors and retail pharmacies in the US. Assertio also licenses Acuform, its proprietary drug delivery technology to pharmaceutical companies for product development. Assertio is headquartered in Lake Forest, Illinois, the US.

Assertio Therapeutics Inc Key Recent Developments

Mar 09,2020: Assertio Therapeutics announces fourth-quarter and full-year 2019 financial results
Mar 02,2020: Assertio Therapeutics to report fourth quarter and full year 2019 financial results after the close of markets on Monday, March 9, 2020
Feb 07,2020: Assertio to divest US rights to Nucynta to Collegium for $375m
Feb 06,2020: Assertio Therapeutics announces sale of NUCYNTA Franchise to Collegium Pharmaceutical for $375.0 Million
Nov 06,2019: Assertio Therapeutics announces third-quarter 2019 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Assertio Therapeutics Inc – Key Facts
Assertio Therapeutics Inc – Key Employees
Assertio Therapeutics Inc – Key Employee Biographies
Assertio Therapeutics Inc – Major Products and Services
Assertio Therapeutics Inc – History
Assertio Therapeutics Inc – Company Statement
Assertio Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Assertio Therapeutics Inc – Business Description
Product Category: CAMBIA
Overview
Performance
Product Category: Gralise
Overview
Performance
Product Category: Zipsor
Overview
Performance
Assertio Therapeutics Inc – Corporate Strategy
Assertio Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Assertio Therapeutics Inc – Strengths
Assertio Therapeutics Inc – Weaknesses
Assertio Therapeutics Inc – Opportunities
Assertio Therapeutics Inc – Threats
Assertio Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Assertio Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 09, 2020: Assertio Therapeutics announces fourth-quarter and full-year 2019 financial results
Feb 07, 2020: Assertio to divest US rights to Nucynta to Collegium for $375m
Nov 06, 2019: Assertio Therapeutics announces third-quarter 2019 results
Sep 30, 2019: Assertio Therapeutics announces appointment of Dr. David Wheadon to its Board of Directors
Aug 07, 2019: Assertio Therapeutics announces strong second-quarter 2019 results
May 08, 2019: Assertio Therapeutics announces first-quarter 2019 financial results
Apr 01, 2019: Assertio Therapeutics names Jay Galeota to board of directors
Mar 06, 2019: Assertio Therapeutics announces fourth-quarter and full-year 2018 financial results
Feb 19, 2019: Assertio Therapeutics announces appointment of Heather L. Mason to Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Assertio Therapeutics Inc, Key Facts
Assertio Therapeutics Inc, Key Employees
Assertio Therapeutics Inc, Key Employee Biographies
Assertio Therapeutics Inc, Major Products and Services
Assertio Therapeutics Inc, History
Assertio Therapeutics Inc, Subsidiaries
Assertio Therapeutics Inc, Key Competitors
Assertio Therapeutics Inc, Ratios based on current share price
Assertio Therapeutics Inc, Annual Ratios
Assertio Therapeutics Inc, Annual Ratios (Cont...1)
Assertio Therapeutics Inc, Annual Ratios (Cont...2)
Assertio Therapeutics Inc, Interim Ratios
Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Assertio Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Assertio Therapeutics Inc, Performance Chart (2015 - 2019)
Assertio Therapeutics Inc, Ratio Charts
Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Assertio Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Assertio Therapeutics Inc (ASRT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Altadis U.S.A., Inc.:企業の戦略・SWOT・財務情報
    Altadis U.S.A., Inc. - Strategy, SWOT and Corporate Finance Report Summary Altadis U.S.A., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Stena AB:企業の戦略的SWOT分析
    Stena AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Shaheen Insurance Company Limited:企業の戦略・SWOT・財務情報
    Shaheen Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Shaheen Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • UPL Ltd (UPL):企業の財務・戦略的SWOT分析
    UPL Ltd (UPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Magnis Energy Technologies Ltd (MNS):企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Packages Limited:企業の戦略・SWOT・財務情報
    Packages Limited - Strategy, SWOT and Corporate Finance Report Summary Packages Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Magenta Therapeutics Inc (MGTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Magenta Therapeutics Inc (Magenta Therapeutics) formerly HSCTCo Therapeutics Inc, is a clinical-stage biotechnology company focused on developing novel medicines which revolutionizes bone marrow transplant for treating autoimmune diseases, blood cancers and rare genetic diseases. Its product …
  • Tahoe Resources Inc.:企業の戦略・SWOT・財務情報
    Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析
    Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Corbion NV:企業のM&A・事業提携・投資動向
    Corbion NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corbion NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • BioVentrix Inc-医療機器分野:企業M&A・提携分析
    Summary BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company provides revivent myocardial anchoring systems that restore the size, volume and resulting function of the left ventricle for improving cardiac function in heart fa …
  • Reviva Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Reviva Pharmaceuticals Inc (Reviva Pharma) is a clinical development pharmaceutical company that develops therapeutic drugs. The company develops drugs in the therapeutic areas of cardiovascular, metabolic, central nervous system and inflammatory diseases. Its product pipeline comprises RP50 …
  • Energias de Portugal SA (EDP)-エネルギー分野:企業M&A・提携分析
    Summary Energias de Portugal, S.A. (EDP) is a vertically integrated power and gas utility that generates, transmits, distributes and sells electricity; and transports, distributes and sells natural gas. It produces electricity through a diversified portfolio of generation assets including wind, sola …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Hitec Power Protection BV:企業の戦略的SWOT分析
    Hitec Power Protection BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Neovacs SA (ALNEV):製薬・医療:M&Aディール及び事業提携情報
    Summary Neovacs SA (Neovacs) is a biotechnology company that develops various therapeutic vaccines for the treatment of autoimmune disorders, inflammatory diseases and cancers. The company offers TNF- kinoid and IFNalpha- kinoid products used for the treatment of rheumatoid arthritis, Crohn’s diseas …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • UniQure NV (QURE):製薬・医療:M&Aディール及び事業提携情報
    Summary UniQure NV (UniQure) develops and markets gene therapy products. The company develops adeno-associated virus based gene therapies using its gene technology platform. UniQure offers clinical and preclinical programs for lipoprotein lipase deficiency, hemophilia A and B, Huntington’s disease, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆